1. On the regulatory approval pathway of biosimilar products;Wang;Pharmaceuticals,2012
2. Statistical and regulatory considerations in assessments of interchangeability of biological drug products;Tóthfalusi;Eur J Health Econ,2014
3. Questions and answers on biosimilar medicines (similar biological medicinal products) 2012 http://www.medicinesforeurope.com/wp-content/uploads/2016/03/WC500020062.pdf
4. Interchangeability of biosimilars-position of Finnish Medicines Agency Fimea 2015 https://www.fimea.fi/documents/542809/838272/29197_Biosimilaarien_vaihtokelpoisuus_EN.pdf
5. Guide to biosimilars for healthcare professionals and patients https://www.hpra.ie/docs/default-source/publications-forms/guidance-documents/guide-to-biosimilars-for-healthcare-professionals-and-patients-v2.pdf?sfvrsn=18 2015